4[4]Dellinger RP, Carlet JM, Masur H, et al.Surviving sepsis campaign guidelines for management of severe sepsis and septic shock[J]. Intensive Care Med, 2004, 30: 536-555.
5[5]Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents[J]. Chest, 1989, 95(1): 2s-4s.
6[6]Kurwa S, Esmon CT, Steams- Kurosawa DJ. The soluble endothelial protein C receptor binds to activated neutrophils: involvement of proteinases3 and CDl1b/CD18[J]. J Immunol, 2000, 165(10): 4697-4703.
7[7]White B, Schmidl M, Murphy C, et al. Activated protein C inhibits LPS induced nuclear translocation of nuclear kB and tumor necrosis factor - a production in the THP1 monocytic cell line[J]. Br J Hae Matol, 2000,110: 130- 134.
8[8]Hesselvik J. Protein C, Protein S and C4b binding protein in severe infection and septic shock[J]. Thromb Hae Matol, 1991, 65:126 -129.
9[9]Bernard GR, Vincent JL, Laterre PF, et al. Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis [J]. Crit Care Med, 2001, 29(11): 2051-2059.
10[10]Bernard GR, Vincent TL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis[J]. N Engl J Med, 2001, 344(8): 699-709.
二级参考文献11
1Chaudry I H.Sepsis lessons learned in the last century and future directions〔J〕[].Archives of Surgery.1999
2Sriskandan S,moyes D,Cohen J.Detection of circulating bacterial superantigen and lymphotoxin in patients with streptococcal toxic shock syndrome〔J〕[].The Lancet.1996
3Opal S M,Cohen J.Clinical gram positive sepsis: dose it fundamentally differ from gram negative bacterial sepsis 〔J 〕[].Critical Care Medicine.1999
4Friedland L S,Porter J C,Daryanani S,et al.Plasma proinflammatory cytokine concentration: acute physiology and chronic health evaluation (APACHE)Ⅲ scores and survival in patients in an intensive care unit 〔J〕[].Critical Care Medicine.1996
5Valles J,Leon C,Ledrma A,et al.Nosocomial bacteremia in critically ill patients: a multicenter study evaluating epidemiology and prognosis〔J〕[].Clinical Infectious Diseases.1997
6Baker C C,Chaudry I H,Gaines H O,et al.Evaluation of factors affecting mortality rate after sepsis in murine cecal ligation and puncture model 〔J〕[].Journal of Surgery.1983
7Bone R C.Gram positive organisms and sepsis〔J〕[].Archives of Internal Medicine.1994
8Hebert P,Wells G,Blajchman M A,et al.A multicenter, randomized controlled clinical trial of transfusion requirements in critical care〔J〕[].The New England Journal of Medicine.1999
9Sriskandan S,Moyes D,Buttery L D,et al.Streptococcal pyrogenic exotoxin a release: gram negative sepsis: a meta analysis 〔J 〕[].Journal of Clinical Microbiology.1994
10Bartlett J G,Onderdonk A B,Louie T,et al.Lessons from an animal model of intra abdominal sepsis: a review〔J 〕[].Archives of Surgery.1978
